Fundraising Fox

Celmatix

New York, US · Delaware corporation · 1 known investors

celmatix.com ↗

Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.

BiotechFemTechHealthtechin /celmatix@celmatix

Founders & leadership

PY
Piraye Yurttas BeimExecutive Officer, Director
SW
Steven WinickDirector
LT
Laura Towart BandakDirector

Investors · 1

Lauder PartnersLos Altosvia Gary Lauder · inferred

Reported raises · per SEC filings

Form D private placements
▶$4.8MraisedApr 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Piraye Yurttas BeimExecutive Officer, Director
  • Laura BandakDirector
  • Steven J. WinickDirector
Offering amount
$4.8M
Amount sold
$4.8M
First sale
Mar 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedSep 2015 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Piraye Yurttas BeimExecutive Officer, Director
  • Steven J. WinickDirector
  • Laura BandakDirector
Offering amount
$5.2M
Amount sold
$3.8M
First sale
Aug 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.5MraisedJul 2015 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Piraye Yurttas BeimExecutive Officer, Director
  • Steven WinickDirector
  • Laura Towart BandakDirector
Offering amount
$5.5M
Amount sold
$5.5M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news